Kymera Therapeutics (KYMR) FCF Margin Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) FCF Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kymera Therapeutics | 10.77 Bn | 10.11 Bn | - | 10,048.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,048.00 |
| Dec 31, 2025 | -168,025.00 |
| Sep 30, 2025 | 34,919.00 |
| Jun 30, 2025 | -34,220.00 |
| Mar 31, 2025 | 9,656.00 |
| Dec 31, 2024 | -86,695.00 |
| Sep 30, 2024 | -97,976.00 |
| Jun 30, 2024 | 9,304.00 |
| Mar 31, 2024 | 5,002.00 |
| Dec 31, 2023 | 25,459.00 |
| Sep 30, 2023 | 1,504.00 |
| Jun 30, 2023 | 6,626.00 |
| Mar 31, 2023 | -8,305.00 |
| Dec 31, 2022 | 2,105.00 |
| Sep 30, 2022 | -18,712.00 |
| Jun 30, 2022 | -17,684.00 |
| Mar 31, 2022 | -30,088.00 |
| Dec 31, 2021 | -15,965.00 |
| Sep 30, 2021 | -107,414.00 |
| Jun 30, 2021 | 29,619.00 |